We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

#What Is the Estimated Market Size of the Transcriptomics Market In 2029?#_x000D_

In recent times, there has been a significant growth in the transcriptomics market size. Projected to increase from $6.51 billion in 2024 to $7.06 billion in 2025, it is expected to enjoy a compound annual growth rate (CAGR) of 8.5%. The historic period’s growth is principally due to factors such as heightened attention towards personalized medicine, a rise in cancer cases, the utilization of genomics in clinical diagnostic procedures, the broadening scope of ribonucleic acid sequencing, and the surge in demand for biomarker discovery._x000D_

_x000D_

We can anticipate a solid expansion of the transcriptomics market in the upcoming years. By 2029, the market is projected to balloon to $9.65 billion, growing at a compound annual growth rate (CAGR) of 8.1%. The spurt in growth during this period can be traced back to several factors, such as the increased use of single-cell ribonucleic acid sequencing, larger integration of spatial transcriptomics, upsurge in demand for multiomics methods, a heightened emphasis on early diagnosis of diseases, and a growing understanding of the significance of non-coding ribonucleic acids. Key trends throughout the forecast period include progress in next-generation sequencing (NGS) technologies, technological enhancements in spatial transcriptomics, development in bioinformatics tools, the inclusion of machine learning within transcriptomics, and advancements in real-time transcriptomic analysis technology._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp_x000D_

_x000D_

#What Are the Major Market Drivers Behind the Rising Adoption of Transcriptomics Market?#_x000D_

The surge in personalized medicine use is set to fuel the expansion of the transcriptomics market. Personalized medicine is a medical methodology that tailors treatment to an individual’s genetic profile, lifestyle, and surroundings. The growth of this field is driven by advancements in genetic sequencing, which allows treatments to be customized to a person’s specific genetic makeup, thus improving effectiveness. Transcriptomics helps to reveal individual gene expression profiles, providing direction for personalized treatments based on one’s unique biological makeup. This heightens the potency of therapies, reduces side effects, and aids in early disease detection. For example, as reported by the Personalized Medicine Coalition in February 2024, a US-based hospital and health care organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, an increase from six in 2022. Given this, the rising uptake of personalized medicine is propelling the development of the transcriptomics market._x000D_

_x000D_

#Which Key Market Segments Comprise the Transcriptomics Market and Drive Its Revenue Growth?#_x000D_

The transcriptomics market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Instruments, Consumables, Software, Services_x000D_

2) By Technology: Micro Array, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies_x000D_

3) By Application: Diagnostics And Disease Profiling, Drug Discovery, Other Applications_x000D_

4) By End-User: Academic And Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Instruments: Microarray Instruments, Sequencing Instruments, Polymerase Chain Reaction (PCR) Instruments, Other Transcriptomics Instruments_x000D_

2) By Consumables: Reagents, Probes, Kits, Chips_x000D_

3) By Software: Data Analysis Software: Data Management Software, Visualization Software: Bioinformatics Software_x000D_

4) By Services: Data Analysis Services, Sample Preparation Services, Sequencing Services, Consulting Services_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Transcriptomics Market Expansion Across the Globe?#_x000D_

North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Strategic Trends Steering the Transcriptomics Market Direction?#_x000D_

Prominent companies in the transcriptomics market are concentrating on the creation of state-of-the-art products like single-cell spatial panels, in order to gain more profound understanding of cell functions and disease processes. This type of panels can examine gene expression at the individual cell level, while still preserving each cell’s position within the tissue. By combining single-cell transcriptomics with spatial data, they provide insights into both cell activities and tissue structure. For instance, NanoString Technologies, an American biotech company, introduced the CosMx 6,000 plex RNA Assay in February 2024, which is a spatial molecular imaging assay. The inception of this product signifies the commercial introduction of the first single-cell spatial panel in the industry, which has the capacity to measure more than 6,000 RNA targets across almost every human biological pathways. Engineered to be utilized with the CosMx Spatial Molecular Imager (SMI), this innovation allows scientists to profile genes with exceptional accuracy and advanced cell segmentation at single-cell and subcellular resolution._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report_x000D_

_x000D_

#How Is the Transcriptomics Market Conceptually Defined?#_x000D_

Transcriptomics is the study of all ribonucleic acid (RNA) transcripts produced by the genome in a specific cell, tissue, or condition. It helps decode gene expression patterns and regulatory mechanisms, revealing how these change in response to diseases or environmental factors. This field offers deep insights into cellular functions and disease pathways. Transcriptomics is crucial for biomarker discovery, therapeutic target identification, and advancing personalized medicine._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24417&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model